| Sandu Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524703 |
NSE Symbol : - |
P/E(TTM) : 19.18 |
|
ISIN Demat : INE751D01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.83 |
|
Book Value(₹) : 36.48 |
Market Cap(₹Cr) : 33.91 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 16.39 | 16.85 | 18.76 | 17.62 | 16.70 | 14.07 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 16.39 | 16.85 | 18.76 | 17.62 | 16.70 | 14.07 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.02 | 0.37 | 0.01 | 0.05 | 0.02 | 0.07 |
| Total Income | 16.41 | 17.22 | 18.77 | 17.67 | 16.72 | 14.14 |
| Total Expenditure | 15.85 | 16.28 | 17.72 | 16.76 | 16.17 | 13.62 |
| PBIDT | 0.55 | 0.94 | 1.05 | 0.91 | 0.54 | 0.52 |
| Interest | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| PBDT | 0.52 | 0.91 | 1.02 | 0.88 | 0.52 | 0.49 |
| Depreciation | 0.16 | 0.16 | 0.17 | 0.17 | 0.18 | 0.15 |
| Tax | 0.09 | 0.54 | -0.05 | 0.20 | 0.10 | 0.07 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.04 | 0.16 | -0.07 | -0.01 | 0.02 | -0.06 |
| Reported Profit After Tax | 0.23 | 0.04 | 0.98 | 0.52 | 0.22 | 0.33 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.23 | 0.04 | 0.98 | 0.52 | 0.22 | 0.33 |
| EPS (Unit Curr.) | 0.37 | 0.04 | 1.01 | 0.54 | 0.23 | 0.34 |
| EPS (Adj) (Unit Curr.) | 0.37 | 0.04 | 1.01 | 0.54 | 0.23 | 0.34 |
| Calculated EPS (Unit Curr.) | 0.24 | 0.04 | 1.01 | 0.54 | 0.23 | 0.34 |
| Calculated EPS (Adj) (Unit Curr.) | 0.24 | 0.04 | 1.01 | 0.54 | 0.23 | 0.34 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.94 | 0.18 | 4.04 | 2.17 | 0.92 | 1.35 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.94 | 0.18 | 4.04 | 2.17 | 0.92 | 1.35 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 9.66 | 9.66 | 9.66 | 9.66 | 9.66 | 9.66 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 32.57 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 3.36 | 5.58 | 5.60 | 5.16 | 3.23 | 3.70 |
| PBDTM(%) | 3.17 | 5.40 | 5.44 | 4.99 | 3.11 | 3.48 |
| PATM(%) | 1.40 | 0.24 | 5.22 | 2.95 | 1.32 | 2.35 |
